Cross-cultural adaptation and validation of the PedsQL™ stem cell transplant module in China: A methodological and

Yuting Wei1, Heng Zhang1, Xiaowen Qian2

  • 1Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University, Nanjing, China.

Frontiers in Pediatrics
|January 23, 2023
PubMed

Insights

This study translated the Pediatric Quality of Life Inventory™ (PedsQL™) Stem Cell Transplant Module into Chinese for pediatric Hematopoietic stem cell transplantation (HSCT) survivors. The Chinese version is a reliable and valid tool for assessing quality of life in these children.

Area of Science:

  • Pediatric Oncology
  • Health Outcomes Research
  • Translational Research

Background:

  • Hematopoietic stem cell transplantation (HSCT) has improved survival rates in children.
  • There is a need for validated quality of life (QoL) assessment tools for pediatric HSCT patients in China.
  • This study addresses the lack of culturally adapted QoL measures for Chinese pediatric HSCT survivors.

Purpose of the Study:

  • To translate and culturally adapt the English Pediatric Quality of Life Inventory™ (PedsQL™) Stem Cell Transplant Module into a Chinese mandarin version.
  • To evaluate the reliability and validity of the translated Chinese PedsQL™ Stem Cell Transplant Module.
  • To provide a tool for assessing QoL in Chinese children undergoing HSCT.

Main Methods:

  • The PedsQL™ Stem Cell Transplant Module and PedsQL™ 4.0 Generic Core Scales were administered to 120 children (ages 2-18) and their parents in China.
  • Feasibility was assessed by completion rates and missing item percentages.
  • Reliability was evaluated using internal consistency (Cronbach's alpha) and test-retest reliability.
  • Validity was assessed through factor analysis and correlation analyses.

Main Results:

  • The Chinese PedsQL™ Stem Cell Transplant Module demonstrated high feasibility with low item non-response rates.
  • Internal consistency (Cronbach's alpha) was ≥0.70 for most dimensions in both child and parent reports.
  • Test-retest reliability was good (0.685 for parents, 0.765 for children).
  • Factor analysis identified eight underlying factors, explaining 74.54% of the variance.
  • Strong correlations were found between the PedsQL™ 4.0 and the Transplant Module scores (0.748 child self-report, 0.808 parent proxy-report).

Conclusions:

  • The Chinese mandarin version of the PedsQL™ Stem Cell Transplant Module is a feasible, reliable, and valid instrument.
  • This validated tool can effectively assess the quality of life for Chinese children after HSCT.
  • The findings support the use of this translated module in clinical practice and research for improved patient care.
Abstract

Related Concept Videos